Manufacturing

Is Leadership Reshaping the Future of Biopharma CDMOs?
Biotech & Bioprocessing Is Leadership Reshaping the Future of Biopharma CDMOs?

The biopharmaceutical sector has witnessed significant changes in leadership roles within major Contract Development and Manufacturing Organizations (CDMOs), driving strategic growth and development. The appointment of seasoned leaders plays a crucial role in strengthening the research,

How Will Landmark Bio Shape Artis Biosolutions' Future?
Biotech & Bioprocessing How Will Landmark Bio Shape Artis Biosolutions' Future?

Artis Biosolutions' acquisition of Landmark Bio marks a strategic move designed to bolster cell and gene therapy (CGT) manufacturing capabilities. Landmark Bio, founded by Harvard University, MIT, Fujifilm Diosynth Biotechnologies, Alexandria Real Estate Equities, and Cytiva, has been a key player

Impact of Peter Marks' Departure on Cell and Gene Therapy at FDA
Research & Development Impact of Peter Marks' Departure on Cell and Gene Therapy at FDA

The recent resignation of Peter Marks as the head of the FDA's Center for Biologics Evaluation and Research (CBER) marks a significant moment for the cell and gene therapy industry. His departure has sparked widespread discussion about the future direction of the regulatory landscape and its

Epic Medical to Bring $25M Manufacturing Facility to Pekin, Illinois
Management & Regulatory Epic Medical to Bring $25M Manufacturing Facility to Pekin, Illinois

Epic Medical, headquartered in Singapore, is poised to significantly impact Pekin, Illinois, by investing $25 million in a new medical equipment manufacturing facility. Announced during a well-attended news conference in the Pekin City Council meeting room, the agreement was formalized by Mayor

How Is Africa Enhancing Its Health Regulatory Leadership?
Management & Regulatory How Is Africa Enhancing Its Health Regulatory Leadership?

In a groundbreaking initiative aimed at transforming the health regulatory landscape across the African continent, the first African Regulators Leadership Program (ARLP) was convened at the Wits Business School in Johannesburg. This program is designed to elevate the leadership skills and

Is Sutro Biopharma's Restructuring the Key to Long-Term Survival?
Management & Regulatory Is Sutro Biopharma's Restructuring the Key to Long-Term Survival?

In a surprising move, Sutro Biopharma has decided to undertake a sweeping restructuring plan with the primary goal of conserving capital, leading to a nearly 50% reduction in its workforce, the ousting of CEO Bill Newell, the discontinuation of its lead drug candidate luveltamab tazevibulin

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later